Back to Trades
Total Value
$143.0K
Filing Date
Jul 23, 2026
1 transactions
Trade Summary
On Jul 21, 2026, Jahr Robert Charles, Chief Executive Officer, Director, reported $143.0K of Outlook Therapeutics, Inc. (OTLK) across 1 transactions. The filing covers company securities and reflects balanced net activity of $0. Reported prices ranged from $1.43. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- Outlook Therapeutics, Inc.
- Ticker Symbol
- OTLK
- CIK
- 0001649989
Insider Information
- Role
- Chief Executive Officer, Director
- Location
- ISELIN, NJ
Filing Details
- Filing Date
- Jul 23, 2026
- Transaction Date
- Jul 21, 2026
- Accession Number
- 0001649989-26-000006
- Form Type
- 4
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Jul 21, 2026 | OTLK derivative | 100,000 | $1.43 | Grant/Award | $143.0K |
Want live alerts when Jahr Robert Charles trades again?
Download Insider Trades to track OTLK, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)The option was granted to Mr. Jahr on July 21, 2026, pursuant to the Issuer's 2024 Equity Incentive Plan and the Issuer's standard form of stock option agreement thereunder. The option vests and becomes exercisable in full on July 21, 2027, subject to Mr. Jahr's continuing service with the Issuer through such vesting date.